S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Gershon Y. Locker · Study
Home
/
Author
Gershon Y. Locker
2 works
· latest 2007
· 1 institutions
cluster: provisional
ORCID 0000-0002-6869-8738
Follow
Suggest an ORCID correction
h-index
2
i10
2
Citations
135
Works here
2
07
Most cited in this library
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial
2007 · 74 citations
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial
2007 · 61 citations
Works
2 shown
Cost-effectiveness analysis of anastrozole vs tamoxifen in adjuvant therapy for early stage breast cancer in the United Kingdom: the 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen alone or in combination) trial
British Journal of Cancer
·
2007
·
5 authors
·
Open access
61
citations
Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial
Breast Cancer Research and Treatment
·
2007
·
6 authors
74
citations